- Home
- / Jin Medical International
- / Financials
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
Jin Medical International financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.
Stock Price
$2.1
2024-10-29
Market Capitalization
$322.5 M
2024-10-29
Revenue
$20.7 M
FY, 2025
CreditSafe Score
?
Score changed on Jun 11, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| USD | FY, 2019 | FY, 2020 | FY, 2021 | FY, 2022 | FY, 2023 | FY, 2024 | FY, 2025 |
|---|---|---|---|---|---|---|---|
| Revenue | 20.4M | 16.2M | 20.8M | 19.2M | 19.8M | 23.5M | 20.7M |
| Cost of goods sold | 12.5M | 10.4M | 14.1M | 12.6M | 12.8M | 13.8M | 14.4M |
| Gross profit | 7.9M | 5.8M | 6.7M | 6.6M | 7.0M | 9.7M | 6.3M |
| Gross profit margin, % | 38.6% | 36.0% | 32.3% | 34.2% | 35.4% | 41.4% | 30.4% |
| Operating expense total | 3.1M | 3.1M | 3.7M | 4.1M | 3.9M | 5.9M | 5.4M |
| Depreciation and amortization | 349.0K | 330.0K | 347.0K | 362.0K | 226.0K | 238.0K | 243.0K |
| EBITDA | 4.8M | 2.7M | 3.0M | 2.5M | 3.1M | 3.9M | 852.0K |
| EBITDA margin, % | 23.3% | 16.6% | 14.3% | 13.0% | 15.6% | 16.5% | 4.1% |
| EBIT | 4.5M | 2.5M | 2.8M | 2.4M | 3.1M | 3.7M | 784.0K |
| EBIT margin, % | 22.0% | 15.3% | 13.6% | 12.4% | 15.6% | 15.9% | 3.8% |
| Interest income | 182.0K | 183.0K | 467.0K | 789.0K | |||
| Interest expense | 23.0K | 112.0K | 9.0K | ||||
| Pre tax profit | 4.1M | 2.4M | 2.9M | 2.7M | 3.2M | 4.2M | 1.6M |
| Income tax expense | 480.0K | 147.0K | 248.0K | 36.0K | 344.0K | 764.0K | 215.0K |
| Net Income | 3.6M | 2.2M | 2.6M | 2.7M | 2.9M | 3.4M | 1.4M |